Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance
Rodriguez L, Pou C, Lakshmikanth T, Zhang J, Mugabo CH, Wang J, Mikes J, Olin A, Chen Y, Rorbach J, et al.
Oxford Open Immunology · 2023
Key finding
A study targeting the neuro-immune axis to relieve symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
Auto-extracted · verification pendingHow we verify
- Condition
- Chronic Fatigue Syndrome
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Share this study
Download the citation card as a PNG, or copy a link to this page.
Cite this study
Rodriguez, L., Pou, C., Lakshmikanth, T., Zhang, J., Mugabo, C. H., Wang, J., Mikes, J., Olin, A., Chen, Y., Rorbach, J., Juto, J. E., Li, T. Q., Julin, P., & Brodin, P. (2023). Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance. Oxford Open Immunology, 4(1). https://doi.org/10.1093/oxfimm/iqad003
Related studies in Chronic Fatigue Syndrome
Potential application of brain-gut axis-based treatments in Long COVID and ME/CFS: a case-based systematic review
Kim et al. · Journal of translational medicine · 2026 · Systematic Review / Meta-Analysis
Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials
Yang et al. · Therapeutic advances in chronic disease · 2023 · Systematic Review / Meta-Analysis
The effects of non-invasive vagus nerve stimulation on fatigue in participants with primary Sjogren's syndrome
Tarn et al. · Neuromodulation · 2023 · Randomised Controlled Trial
Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial
Contreras et al. · JMIR research protocols · 2023 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.